Nutritional and Metabolic Dynamics of Thru-Hiking: A Longitudinal Study on the Colorado Trail

January 9, 2025 updated by: University of Minnesota

Thru-hiking the Colorado Trail presents distinct challenges owing to its diverse landscapes and high altitudes. The study aims to delve into the physiological and nutritional facets of extended wilderness trekking among thru-hikers. Activities encompass participant recruitment from the Colorado Trail Foundation community, baseline and post-trail assessments including blood lipid panel analysis and anthropometric measurements, data collection during the trail period involving recording daily mileage, exertion levels, and dietary intake, rigorous statistical analysis to explore correlations among various parameters, and adherence to ethical considerations including obtaining formal approval and ensuring informed consent procedures are followed to safeguard participants' rights and privacy. Through this endeavor, the study seeks to offer insights into the metabolic responses and cardiovascular implications associated with thru-hiking, shedding light on the interplay between diet, lifestyle factors, and metabolic health in challenging environments.

The specific aims include examining the metabolic responses and cardiovascular implications associated with thru-hiking, exploring correlations between dietary intake and blood lipid profiles, and elucidating the interplay between lifestyle factors and metabolic health in demanding environments. This study is not limited to program evaluation, quality assurance, or improvement activities within a specific department or setting but rather seeks to contribute to scientific knowledge and inform evidence-based recommendations for individuals engaging in thru-hiking or similar high-intensity activities.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

15

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Minneapolis, Minnesota, United States, 55455
        • University of Minnesota

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

individuals hiking The Colorado Trail in its entirety in summer 2024. Excluded are those having hiked another thru-hike 6 months prior.

Description

Inclusion Criteria:

  • Thru-Hikers on the Colorado Trail:
  • Individuals planning to commence their thru-hiking journey on the Colorado Trail in early July.

Residence:

  • Participants must reside in northern Colorado.
  • Thru-Hiking History
  • Participants must not have completed another thru-hike in the past 6 months.
  • Informed Consent
  • Individuals interested in participating in the study must provide informed consent.

Exclusion Criteria:

  • Individuals who have completed another thru-hike in the past 6 months
  • children below the age of majority, pregnant women, fetuses, and neonates
  • prisoners, adults lacking the capacity to consent or with fluctuating capacity, non-English speakers, and illiterate individuals
  • employees or students of the researcher
  • individuals from undervalued or disenfranchised social groups
  • Active members of the military, including Department of Defense (DoD) personnel
  • individuals in stressful situations, those disadvantaged in social goods and services and individuals with serious health conditions lacking standard treatments
  • those with a fear of negative consequences for not participating and individuals facing circumstances increasing vulnerability to coercion or exploitation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
thru-hiking on the Colorado Trail

Thru-hikers planning to embark on the Colorado Trail are recruited through the Colorado Trail Foundation community page and email newsletter, ensuring a sample population representative of those undertaking this challenging endeavor.

Participants will be tracked over time to assess changes in their metabolic health and dietary habits.

planning to embark on the Colorado Trail

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
blood lipid panel: total cholesterol
Time Frame: baseline and 2 days post-hike
changes in total cholesterol levels from baseline to within 2 days of completing the Colorado Trail.
baseline and 2 days post-hike
blood lipid panel: high-density lipoprotein (HDL)
Time Frame: baseline and 2 days post-hike
changes in HDL levels from baseline to within 2 days of completing the Colorado Trail.
baseline and 2 days post-hike
blood lipid panel: low-density lipoprotein (LDL)
Time Frame: baseline and 2 days post-hike
changes in LDL levels from baseline to within 2 days of completing the Colorado Trail.
baseline and 2 days post-hike
blood lipid panel: triglycerides
Time Frame: baseline and 2 days post-hike
changes in triglycerides levels from baseline to within 2 days of completing the Colorado Trail.
baseline and 2 days post-hike

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Stephen Selinsky, MD, University of Minnesota

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2024

Primary Completion (Actual)

September 1, 2024

Study Completion (Actual)

December 1, 2024

Study Registration Dates

First Submitted

April 4, 2024

First Submitted That Met QC Criteria

April 4, 2024

First Posted (Actual)

April 10, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 9, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • MED-2024-32848

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Thru-hiking

Clinical Trials on Thru-hiking

Subscribe